Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

The Use of Transcranial Direct Current Stimulation (TDCS) to Enhance the Rehabilitative Effect of Vision Restoration Therapy

Early Phase 1

Completed

Conditions: Hemianopia
Quadrantanopia
Scotoma
Visual Field Loss

Interventions: Behavioral: Vision Restoration Therapy (VRT)
Device: Transcranial direct current stimulation (tDCS)

First Posted Date: 2009-06-16

Last Posted Date: 2012-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00921427

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles

Phase 2

Completed

Conditions: Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

Interventions: Drug: Enoxaparin

First Posted Date: 2009-05-27

Last Posted Date: 2017-12-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 70

Registration Number: NCT00908960

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Southern California-Keck School of Medicine, Los Angeles, California, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 2 locations

Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation Study

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Computer-based Problem-Solving Treatment

First Posted Date: 2009-05-21

Last Posted Date: 2017-04-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 68

Registration Number: NCT00906581

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia

Phase 3

Completed

Conditions: Stroke
Apoplexy
Cerebral Infarction
Aphasia
Cerebrovascular Accident

Interventions: Behavioral: Melodic Intonation Therapy
Behavioral: Speech-Repetition-Therapy

First Posted Date: 2009-05-18

Last Posted Date: 2020-09-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 30

Registration Number: NCT00903266

Locations: 🇺🇸
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, Massachusetts, United States

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

Phase 2

Terminated

Conditions: Primary Peritoneal Serous Cancer
Fallopian Tube Cancer
Ovarian Cancer

Interventions: Drug: bevacizumab

First Posted Date: 2009-03-20

Last Posted Date: 2018-05-22

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 5

Registration Number: NCT00866723

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Characterization of Prostate Cancer With 3T MR

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2009-01-28

Last Posted Date: 2024-04-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 236

Registration Number: NCT00831142

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Early Functional Outcomes After Closed Reduction With Pinning Versus Open Reduction Internal Fixation of Wrist Fractures

Not Applicable

Completed

Conditions: Wrist Fractures

Interventions: Procedure: CRPP
Procedure: ORIF

First Posted Date: 2009-01-26

Last Posted Date: 2017-02-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT00828685

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Phase 2

Completed

Conditions: Renal Cancer
Renal Cell Carcinoma

Interventions: Drug: Everolimus

First Posted Date: 2009-01-22

Last Posted Date: 2021-02-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 25

Registration Number: NCT00827359

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer

Phase 2

Completed

Conditions: Hepatocellular Cancer

Interventions: Drug: Sorafenib
Procedure: radiofrequency ablation

First Posted Date: 2008-12-23

Last Posted Date: 2023-06-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00813293

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

CyberKnife for Unresectable Renal Tumors

Not Applicable

Completed

Conditions: Renal Cancer

Interventions: Radiation: Stereotactic radiation
Device: CyberKnife Robotic Radiosurgery System

First Posted Date: 2008-12-11

Last Posted Date: 2017-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 17

Registration Number: NCT00807339

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy